NICE's prioritisation board: focus on what matters most

We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway. Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4

In this episode we learn how NICE is helping to deliver the government's 10 year health plan. Our guests are the senior responsible officers looking after the three NICE projects. They are: associate director for planning and operations Jenna Dilkes; deputy director for HealthTech Sarah Byron; anddeputy director for medicines evaluation Jac Bouvy.

In this episode, we discuss recent analysis showing significant disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England. We also explore how our new draft recommendations for these medications could increase uptake with our three guests. They are: Dr Waqaar Shah, chair of the type 2 diabetes guideline committee; Dr Soon Song, consultant physician and diabetologist at Sheffield Teaching Hospitals NHS Foundation Trust; Dr Rahul Mohan, a GP and secretary of the Primary Care Diabetes Society. Learn more about: www.nice.org.uk/news/articles/wom…r-type-2-diabetes Read our draft guideline for type 2 diabetes medicines management: www.nice.org.uk/guidance/gid-ng10336/documents/450

Our Health Technology Assessment Innovation Laboratory (HTA Lab) was launched in June 2023 to test and develop creative solutions to complex problems in health technology assessment. Joining us to discuss its first 2 years of success are our guests: Jamie Elvidge, senior scientific adviser at NICE; Jack Turner, deputy director for medicines access at NHS England; and Victoria Jordan, director of value and access policy at the Association of the British Pharmaceutical Industry.

NICE's prioritisation board has been in operation for just over 12 months. In this episode we review the first year and learn more about how decisions are made, incorporating the role of the patient voice. Our guests are Kay Nolan, head of prioritisation and surveillance at NICE, and Carole Pitkeathley, a lay member of NICE’s prioritisation board.

We're joined by health visitor Karen McLean and health psychologist Vivien Swanson, two members of the guideline committee, to discuss the changes made to the updated guideline to support nutrition and weight management in pregnancy, and nutrition in children up to 5 years. Find the guideline here: www.nice.org.uk/guidance/NG247

In this episode we’re going to be learning more about NICE's guidance for robotic assisted surgery. Our guests are Dr Anastasia Chalkidou, NICE’s HealthTech programme director. And John McGrath, consultant urologist at North Bristol NHS Trust, and chair of the NHSE Steering Committee for Robotic Assisted Surgery. Learn more about NICE's guidance for: Robotic-assisted surgery for soft tissue procedures: https://www.nice.org.uk/guidance/HTE21 Robotic-assisted surgery for orthopaedic procedures: https://www.nice.org.uk/guidance/HTE22

To mark endometriosis awareness month this March we discuss the global initiative, Endometriosis Explained, aiming to educate and support those affected by this condition. In this episode, we're joined by Emma Cox, CEO of Endometriosis UK and gynaecologist Christian Becker from the University of Oxford. Find our guideline here: https://www.nice.org.uk/guidance/ng73 And our quality standard here: https://www.nice.org.uk/guidance/qs172

In this episode we’re going to be learning about how NICE is preparing to use artificial intelligence. Dr Pall Jonsson, programme director for data and real-world evidence at NICE and Dr Stephen Duffield, associate director for real-world evidence at NICE discuss the impact of this dynamic and rapidly advancing field. Find out more about NICE's work in AI and watch our recent webinar at: https://www.nice.org.uk/about/what-we-do/digital-health/artificial-intelligence-at-nice

We're joined by Jules Fielder, who was diagnosed with stage 4 lung cancer in 2021, Dr Jesme Fox, medical director of the Roy Castle Lung Cancer Foundation, Dr Tom Newsom-Davis, consultant medical oncologist at Chelsea and Westminster Hospital, and Chair-Elect of the British Thoracic Oncology Group, and Dr Lynn Campbell, consultant medical oncologist at Belfast City Hospital and committee member for the NICE lung cancer guidelines.